Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation
Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot...
Gespeichert in:
Veröffentlicht in: | Blood coagulation & fibrinolysis 2006-01, Vol.17 (1), p.75-81 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 81 |
---|---|
container_issue | 1 |
container_start_page | 75 |
container_title | Blood coagulation & fibrinolysis |
container_volume | 17 |
creator | Nielsen, Vance G Cohen, Benjamin M Cohen, Eli |
description | Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0–300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy. |
doi_str_mv | 10.1097/01.mbc.0000198047.35010.77 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67846472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67846472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3925-14904c5c808e6789a9365eaf8791547345ae9d9072db80b40846d99dc53830b23</originalsourceid><addsrcrecordid>eNpFkEFv3CAUhFHVqNmm_QuVVam9efswYKC3KkqbSJF6Sc4IYxzTYrMBnFWk_Piw8UrLBYn5Zh5vEPqKYYtB8h-At1NntlAOlgIo3xIGReT8HdpgyknNOCHv0QYk4zVrCDtHH1P6V3hCBf-AznHbAgfBNujlyuuUnamm0C9-SXWnk-2rPMYwdfaghYeod2MhHhc9Zzc4o7MLcxWGalf0SVfGh1wNrotuDv45uVTtXR6rXSxWm5J7sitZ5Ac7V9pk9_SW8QmdDdon-_l4X6D731d3l9f17d8_N5e_bmtDZMNqTCVQw4wAYVsupJakZVYPgkvMyrqUaSt7CbzpOwEdBUHbXsreMCIIdA25QN_X3PKlx8WmrCaXjPVezzYsSZVQ2lJ-AH-uoIkhpWgHtYtu0vFZYVCH7hVgVbpXp-7VW_eK82L-cpyydJPtT9Zj2QX4dgR0MtoPUc_GpRPHyzJl08LRldsHn21M__2yt1GNVvs8rqN5g-sGoC2jAerDCyOvoBmf7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67846472</pqid></control><display><type>article</type><title>Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Nielsen, Vance G ; Cohen, Benjamin M ; Cohen, Eli</creator><creatorcontrib>Nielsen, Vance G ; Cohen, Benjamin M ; Cohen, Eli</creatorcontrib><description>Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0–300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.</description><identifier>ISSN: 0957-5235</identifier><identifier>EISSN: 1473-5733</identifier><identifier>DOI: 10.1097/01.mbc.0000198047.35010.77</identifier><identifier>PMID: 16607085</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams & Wilkins, Inc</publisher><subject>Analysis of Variance ; Aprotinin - pharmacology ; Biological and medical sciences ; Blood coagulation. Blood cells ; Factor XIII - pharmacology ; Fibrinolysis - drug effects ; Fibrinolysis - physiology ; Fibrinolytic Agents - pharmacology ; Fundamental and applied biological sciences. Psychology ; Hematologic and hematopoietic diseases ; Humans ; Kinetics ; Medical sciences ; Molecular and cellular biology ; Platelet diseases and coagulopathies ; Serine Proteinase Inhibitors - pharmacology ; Thrombelastography - methods ; Tissue Plasminogen Activator - pharmacology</subject><ispartof>Blood coagulation & fibrinolysis, 2006-01, Vol.17 (1), p.75-81</ispartof><rights>2006 Lippincott Williams & Wilkins, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3925-14904c5c808e6789a9365eaf8791547345ae9d9072db80b40846d99dc53830b23</citedby><cites>FETCH-LOGICAL-c3925-14904c5c808e6789a9365eaf8791547345ae9d9072db80b40846d99dc53830b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021,27921,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17547904$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16607085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nielsen, Vance G</creatorcontrib><creatorcontrib>Cohen, Benjamin M</creatorcontrib><creatorcontrib>Cohen, Eli</creatorcontrib><title>Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation</title><title>Blood coagulation & fibrinolysis</title><addtitle>Blood Coagul Fibrinolysis</addtitle><description>Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0–300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.</description><subject>Analysis of Variance</subject><subject>Aprotinin - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood coagulation. Blood cells</subject><subject>Factor XIII - pharmacology</subject><subject>Fibrinolysis - drug effects</subject><subject>Fibrinolysis - physiology</subject><subject>Fibrinolytic Agents - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Molecular and cellular biology</subject><subject>Platelet diseases and coagulopathies</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><subject>Thrombelastography - methods</subject><subject>Tissue Plasminogen Activator - pharmacology</subject><issn>0957-5235</issn><issn>1473-5733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFv3CAUhFHVqNmm_QuVVam9efswYKC3KkqbSJF6Sc4IYxzTYrMBnFWk_Piw8UrLBYn5Zh5vEPqKYYtB8h-At1NntlAOlgIo3xIGReT8HdpgyknNOCHv0QYk4zVrCDtHH1P6V3hCBf-AznHbAgfBNujlyuuUnamm0C9-SXWnk-2rPMYwdfaghYeod2MhHhc9Zzc4o7MLcxWGalf0SVfGh1wNrotuDv45uVTtXR6rXSxWm5J7sitZ5Ac7V9pk9_SW8QmdDdon-_l4X6D731d3l9f17d8_N5e_bmtDZMNqTCVQw4wAYVsupJakZVYPgkvMyrqUaSt7CbzpOwEdBUHbXsreMCIIdA25QN_X3PKlx8WmrCaXjPVezzYsSZVQ2lJ-AH-uoIkhpWgHtYtu0vFZYVCH7hVgVbpXp-7VW_eK82L-cpyydJPtT9Zj2QX4dgR0MtoPUc_GpRPHyzJl08LRldsHn21M__2yt1GNVvs8rqN5g-sGoC2jAerDCyOvoBmf7A</recordid><startdate>200601</startdate><enddate>200601</enddate><creator>Nielsen, Vance G</creator><creator>Cohen, Benjamin M</creator><creator>Cohen, Eli</creator><general>Lippincott Williams & Wilkins, Inc</general><general>The Scientist</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200601</creationdate><title>Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation</title><author>Nielsen, Vance G ; Cohen, Benjamin M ; Cohen, Eli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3925-14904c5c808e6789a9365eaf8791547345ae9d9072db80b40846d99dc53830b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Analysis of Variance</topic><topic>Aprotinin - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood coagulation. Blood cells</topic><topic>Factor XIII - pharmacology</topic><topic>Fibrinolysis - drug effects</topic><topic>Fibrinolysis - physiology</topic><topic>Fibrinolytic Agents - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Molecular and cellular biology</topic><topic>Platelet diseases and coagulopathies</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><topic>Thrombelastography - methods</topic><topic>Tissue Plasminogen Activator - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nielsen, Vance G</creatorcontrib><creatorcontrib>Cohen, Benjamin M</creatorcontrib><creatorcontrib>Cohen, Eli</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood coagulation & fibrinolysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nielsen, Vance G</au><au>Cohen, Benjamin M</au><au>Cohen, Eli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation</atitle><jtitle>Blood coagulation & fibrinolysis</jtitle><addtitle>Blood Coagul Fibrinolysis</addtitle><date>2006-01</date><risdate>2006</risdate><volume>17</volume><issue>1</issue><spage>75</spage><epage>81</epage><pages>75-81</pages><issn>0957-5235</issn><eissn>1473-5733</eissn><abstract>Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0–300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.</abstract><cop>Philadelphia, PA</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>16607085</pmid><doi>10.1097/01.mbc.0000198047.35010.77</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0957-5235 |
ispartof | Blood coagulation & fibrinolysis, 2006-01, Vol.17 (1), p.75-81 |
issn | 0957-5235 1473-5733 |
language | eng |
recordid | cdi_proquest_miscellaneous_67846472 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Analysis of Variance Aprotinin - pharmacology Biological and medical sciences Blood coagulation. Blood cells Factor XIII - pharmacology Fibrinolysis - drug effects Fibrinolysis - physiology Fibrinolytic Agents - pharmacology Fundamental and applied biological sciences. Psychology Hematologic and hematopoietic diseases Humans Kinetics Medical sciences Molecular and cellular biology Platelet diseases and coagulopathies Serine Proteinase Inhibitors - pharmacology Thrombelastography - methods Tissue Plasminogen Activator - pharmacology |
title | Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A38%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elastic%20modulus-based%20thrombelastographic%20quantification%20of%20plasma%20clot%20fibrinolysis%20with%20progressive%20plasminogen%20activation&rft.jtitle=Blood%20coagulation%20&%20fibrinolysis&rft.au=Nielsen,%20Vance%20G&rft.date=2006-01&rft.volume=17&rft.issue=1&rft.spage=75&rft.epage=81&rft.pages=75-81&rft.issn=0957-5235&rft.eissn=1473-5733&rft_id=info:doi/10.1097/01.mbc.0000198047.35010.77&rft_dat=%3Cproquest_cross%3E67846472%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67846472&rft_id=info:pmid/16607085&rfr_iscdi=true |